ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Clinical trial NCT07037420 · TERMINATED
Trial details
- NCT number
- NCT07037420
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2026-06-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.